Gastroenterology
3 drugs are in development for Inflammatory Bowel Diseases.
- Companies
- 1
- Clinical trials
- 17
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Inflammatory Bowel Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(3)
| Drug | Company |
|---|---|
| SPY001 | Spyre Therapeutics, Inc. (SYRE) |
| SPY002 | Spyre Therapeutics, Inc. (SYRE) |
| SPY003 | Spyre Therapeutics, Inc. (SYRE) |
About this indication
Inflammatory Bowel Diseases context
Gastroenterology·MeSH: Inflammatory Bowel Diseases (D015212)
Also known as: Inflammatory Bowel Disease
Prevalence
50.7 / 100K
Incidence
5.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Inflammatory Bowel Diseases?
BioSniper tracks 3 drugs in development for Inflammatory Bowel Diseases across 1 company.
How many clinical trials target Inflammatory Bowel Diseases?
There are 17 clinical trials targeting Inflammatory Bowel Diseases tracked by BioSniper.
What is the prevalence of Inflammatory Bowel Diseases?
The estimated prevalence of Inflammatory Bowel Diseases is approximately 50.7 per 100,000 population.